在POU2F-POU2AF转录因子驱动的恶性瘤中准mSWI/SNF复合体
Tongchen He1, Lanbo Xiao2, Yuanyuan Qiao3
1Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI 48109, USA; Department of Pathology, University of Michigan, Ann Arbor, MI 48109, USA; Department of Urology, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China.
小细胞肺癌 (SCLC-P) 和多发性髓瘤易受mSWI/SNF ATPase降解剂的影响. 这种向治疗破坏了关键的转录因子,抑制了瘤的生长,没有毒性.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 染色体生物学 染色体生物学
背景情况:
- POU2F3-POU2AF2/3复合体调节了状细胞和小细胞肺癌 (SCLC) 血统.
- POU2F3驱动的SCLC (SCLC-P) 和POU2F1/2驱动的B细胞恶性瘤代表着不同的癌症亚型.
研究的目的:
- 研究SCLC-P和B细胞恶性瘤对哺乳动物开关/非发酵糖 (mSWI/SNF) 染色质重塑复合物的依赖.
- 评估mSWI/SNF ATPase降解剂在这些癌症中的治疗潜力.
主要方法:
- 使用化向化明体 (PROTAC) 降解剂,向mSWI/SNF ATPases.
- 评估了降解剂对染色质和下游信号传导中的转录因子驱逐的影响.
- 在SCLC-P和多发性髓瘤的临床前模型中测试了一种口服生物可用的mSWI/SNF ATPase降解剂.
主要成果:
- mSWI/SNF ATPase降解剂从SCLC-P细胞中的染色质中驱逐了POU2F3和协同激活剂,减弱了信号传递.
- 治疗还导致多发性骨髓瘤细胞中POU2AF1和IRF4的染色体驱逐,从而降低了IRF4的信号传递.
- 一种口服生物可用的降解剂在SCLC-P和多发性髓瘤模型中显著抑制了瘤生长,没有观察到毒性.
结论:
- 由POU2F-POU2AF驱动的恶性瘤表现出一种特定的依赖mSWI/SNF复合物的活性.
- 用降解剂向mSWI/SNF ATPases代表了对SCLC-P和多发性髓瘤的有希望的治疗策略.
更多相关视频
09:58Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis
Published on: June 27, 2020
07:48Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures
Published on: December 26, 2016
相关概念视频
Abnormal Proliferation
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Induced Pluripotent Stem Cells
Somatic...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
